查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1837192

快速动物试验市场按产品类型、动物类型、技术、应用、最终用户和分销管道划分－2025-2032年全球预测

Veterinary Rapid Test Market by Product Type, Animal Type, Technology, Application, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，快速动物试验市场规模将达到 14.4285 亿美元，复合年增长率为 9.89%。

关键市场统计数据
基准年 2024 6.7839亿美元
预计年份：2025年 7.4501亿美元
预测年份 2032 14.4285亿美元
复合年增长率 (%) 9.89%

一份简洁的策略方向报告，概述了快速动物试验生态系统以及影响诊断创新和市场接受度的汇聚因素。

本执行摘要总结了快速动物侦测的现况和策略讯号，为领导者提供简洁明了、切实可行的决策依据。快速动物诊断技术已成为及时进行临床干预、畜群健康管理以及透过早期检测保护动物和人类群体的监测计划的关键推动因素。检测化学、即时检测平台和分散式检查模式的进步显着提高了人们对诊断速度、易用性和与临床工作流程整合的期望。

此外，法律规范和终端用户偏好也在同步演变，迫使製造商和服务供应商调整产品设计，以满足分析效能、易用性和与数位医疗记录的互通性等要求。因此，相关人员必须兼顾技术创新与实际考量，例如供应链韧性、兽医人员培训要求以及在不同实践环境中的成本效益。以下章节将探讨变革性转变、关税相关动态、市场区隔洞察、区域考量、公司层面策略、可操作说明、方法论以及简明结论，以引导管理者做出明智的策略选择。

技术成熟度、分散式医疗服务、监管完善性和供应链韧性如何共同重塑兽医快速诊断的采用模式

由于技术的成熟、医疗服务模式的转变以及人们对即时诊断期望的不断提高，兽医快速检测领域正在经历显着变化。即时检测平台正从单一分析物读数发展到多重分析，从而在农场、诊所和社区层面提供更广泛的临床价值。检测灵敏度和特异性的同步提升正在缩小快速检测与实验室诊断之间的表现差距，使临床医生能够在首次就诊时做出更有把握的治疗决策。

医疗服务路径的转变也将影响需求模式。远端医疗和远距会诊服务越来越依赖分散式检查来辅助虚拟临床决策，而综合牛管理平台则需要能够将资料传输到分析系统进行疾病监测和生物安全规划的诊断方法。监管机构正不断完善其兽医诊断指南，强调可追溯性、验证标准和上市后监管。

供应链的考量代表着另一个变革方向。那些实现采购多元化、在地化生产并设计出对低温运输要求更为简化的产品的製造商，将更能抵御各种干扰。此外，相关人员也越来越重视以使用者为中心的设计。针对训练需求极低、结果解读迅速的检测方法，正受到兽医技术人员和生产者的青睐，他们既追求速度，也注重结果的清晰度。总而言之，这些转变共同创造了一个环境：技术上的精湛与操作上的实用性必须并存，才能实现更广泛的应用和持续的临床影响。

2025年关税变化和贸易政策转变将如何重塑诊断服务提供者的供应链布局、采购行为和区域商业化策略？

2025年关税调整和贸易政策调整的累积影响，为诊断试剂製造商和经销商的采购、生产布局决策和定价策略带来了新的商业性考量。关税压力促使企业重新评估其跨境供应链，考察近岸外包机会，并重新思考如何将高价值零件分配到区域製造地，以减轻关税的影响。这些调整不仅限于交易层面，还会影响企业在最终组装、品管实验室和库存中心选址方面的策略选择，以确保及时向临床实验室、兽医诊所和现场作业机构交付产品。

同时，关税主导的成本动态正在改变供应商与大型机构买家之间的合约谈判。采购团队越来越要求合约条款中包含关税波动因素，并倾向于选择能够证明其到岸成本稳定的供应商。随着企业调整供应商组合，拥有灵活生产模式的小型创新企业或许能够凭藉应对力或特定领域的性能优势展开竞争，而大型传统企业则可能需要利用其规模和供应链控制来保护利润并维持价格竞争力。

此外，关税使得分销通路策略变得更加重要。能够成功将直销与本地化优化的经销商伙伴关係相结合的公司，可以降低海关延误的风险，并促进跨司法管辖区的收入确认。在此背景下，对海关专业知识、本地监管协调和供应链透明度的战略投资不再是后勤部门考虑因素，而是商业规划的关键组成部分。

深入了解产品类型、动物类别、分析技术、临床应用、使用者类型和通路如何相互作用，从而影响开发重点和商业化策略。

关键的细分洞察揭示了不同检测形式、动物群体、分析技术、临床应用、终端用户和通路的差异化需求如何影响产品开发和上市决策。根据产品类型，诊断试剂可分为酵素结合免疫吸附检测法(ELISA) 和侧向层析免疫检测分析。 ELISA 可进一步分为竞争性、直接、间接和夹心法，而侧向层析免疫分析则发展为竞争性、多重和夹心法设计，以平衡通量、灵敏度和简便性。依动物类型，诊断试剂可分为伴侣动物和家畜两类。辅助型应用程式主要针对猫和狗，着重于门诊临床的便利性。家畜诊断主要针对牛、鸡和猪，群体筛检、速度和成本效益是关键标准。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 将照护现场快速诊断检测纳入常规牲畜健康管理，以降低疾病爆发的风险
  • 采用多重横向流动化验同时检测现场多种动物病原体
  • 开发用于农场通用感染疾病即时检测的携带式微流体装置
  • 小型动物诊所和动物收容所对基于智慧型手机的快速免疫检测平台的需求日益增长
  • 生物技术公司与兽医协会合作，旨在规范整个全部区域的快速检测检验通讯协定。
  • 新兴的基于 CRISPR 的诊断检测方法提高了在临床环境中早期发现动物健康威胁的敏感度。
  • 对专注于恒温核酸增幅以进行牲畜疾病现场检测的兽医诊断Start-Ups的投资增加

第六章美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：按产品类型分類的快速动物实验市场

  • 酵素结合免疫吸附试验
    • 竞争法
    • 直接法
    • 间接法
    • 三明治法
  • 侧向流动免疫检测
    • 竞争法
    • 多路復用方法
    • 三明治法

第九章 按动物类型分類的快速动物实验市场

  • 伴侣动物
    • 猫
    • 狗
  • 家畜
    • 牛
    • 家禽
    • 猪

第十章 按技术分類的快速动物实验市场

  • 比色分析技术
  • 免疫检测
    • 化学冷光
    • ELISA
    • 萤光
    • 侧向流
  • 分子诊断
    • 等温扩增
      • 灯
      • RPA
    • PCR
      • 数位PCR
      • 定量PCR

第十一章 快速动物检测市场（依应用领域划分）

  • 基因检测
    • 突变检测
    • 物种鑑定
  • 荷尔蒙检测
    • 生殖
    • 甲状腺
  • 感染疾病
    • 细菌
    • 真菌
    • 病毒性的
  • 寄生虫感染疾病
    • 体外寄生虫
    • 体内寄生虫

第十二章：按最终用户分類的快速动物测试市场

  • 临床实验室
  • 药局
  • 研究所
  • 兽医诊所

第十三章 快速动物实验市场（依通路划分）

  • 直销
  • 电子商务
  • 零售

第十四章：按地区分類的快速动物检测市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 快速动物实验市场（依群体划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 各国快速动物试验市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • IDEXX Laboratories, Inc.
    • Zoetis Inc.
    • Abbott Laboratories
    • Thermo Fisher Scientific Inc.
    • Heska Corporation
    • Merck & Co., Inc.
    • Boehringer Ingelheim International GmbH
    • Bimeda, Inc.
    • ACON Laboratories, Inc.
    • BioNote Co., Ltd.
Product Code: MRR-034B5003039C

The Veterinary Rapid Test Market is projected to grow by USD 1,442.85 million at a CAGR of 9.89% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 678.39 million
Estimated Year [2025] USD 745.01 million
Forecast Year [2032] USD 1,442.85 million
CAGR (%) 9.89%

A concise strategic orientation that frames the veterinary rapid test ecosystem and the converging forces shaping diagnostics innovation and market adoption

This executive summary synthesizes contemporary developments and strategic signals in the veterinary rapid test landscape to equip leaders with a concise, actionable foundation for decision-making. Rapid diagnostic technologies for animals have emerged as critical enablers of timely clinical intervention, herd health management, and surveillance programs that protect both animal and human populations through early detection. Advances in assay chemistry, point-of-care platforms, and decentralized testing models have collectively shifted expectations for diagnostic speed, usability, and integration with clinical workflows.

Moreover, regulatory frameworks and end-user preferences are evolving in parallel, prompting manufacturers and service providers to align product design with requirements for analytical performance, ease of use, and interoperability with digital health records. As a result, stakeholders must reconcile technical innovation with practical considerations such as supply chain resilience, training requirements for veterinary staff, and cost-effectiveness in diverse practice settings. The following sections unpack transformative shifts, tariff-related dynamics, segmentation insights, regional considerations, company-level strategies, actionable recommendations, methodology, and a concise conclusion to guide executives toward informed strategic choices.

How technological maturation, decentralized care delivery, regulatory refinement, and supply chain resilience are jointly reshaping veterinary rapid diagnostic adoption patterns

The veterinary rapid test landscape is undergoing transformative shifts driven by technological maturation, shifting care delivery models, and heightened expectations for diagnostic immediacy. Point-of-care platforms have progressed from single-analyte readouts to multiplex-capable formats that deliver broader clinical value at the farm, clinic, and community level. Concurrent improvements in assay sensitivity and specificity have narrowed the performance gap between rapid tests and laboratory-based diagnostics, enabling clinicians to make higher-confidence treatment decisions at the first encounter.

Transitioning care pathways also influence demand patterns. Telemedicine and remote consultation services increasingly rely on decentralized testing to inform virtual clinical decision-making, while integrated herd-management platforms demand diagnostics that stream data into analytics systems for disease monitoring and biosecurity planning. Regulatory authorities are continuing to refine guidance for veterinary diagnostics, emphasizing traceability, validation standards, and post-market surveillance, which elevates the bar for manufacturers seeking reproducible clinical performance.

Supply chain considerations represent an additional axis of change. Manufacturers that diversify sourcing, localize production, or design products with simplified cold-chain requirements strengthen their resilience to disruptions. Finally, stakeholders increasingly prioritize user-centered design; tests optimized for minimal training and rapid interpretation gain traction among veterinary technicians and producers who require both speed and clarity. Taken together, these shifts create an environment in which technological sophistication and operational practicality must co-evolve to enable broader adoption and sustained clinical impact.

How 2025 tariff dynamics and trade policy shifts are reshaping supply chain footprints procurement behavior and regional commercialization strategies for diagnostic providers

The cumulative impact of tariff changes and trade policy adjustments in 2025 has introduced new commercial considerations across procurement, manufacturing footprint decisions, and pricing strategies for diagnostic manufacturers and distributors. Tariff pressures have incentivized companies to reassess cross-border supply chains, evaluate nearshoring opportunities, and reconsider the allocation of high-value components to regional manufacturing sites to mitigate duty exposure. These adjustments are not purely transactional; they affect strategic choices about where to locate final assembly, quality control laboratories, and inventory hubs to ensure timely delivery to clinical laboratories, veterinary hospitals, and field operations.

In tandem, tariff-driven cost dynamics have altered contracting conversations between suppliers and large institutional buyers. Procurement teams are more likely to demand contract clauses that account for duty changes or to favor suppliers capable of demonstrating consistent landed costs. As organizations adjust their supplier portfolios, smaller innovators with flexible production models may find opportunities to compete on responsiveness and niche performance advantages, while larger incumbents will need to leverage scale and supply chain control to preserve margin and maintain competitive pricing.

Furthermore, tariffs have amplified the importance of distribution channel strategy. Companies that successfully combine direct sales with regionally optimized distributor partnerships reduce the probability of duty-related delays and smooth revenue recognition across jurisdictions. In this context, strategic investments in customs expertise, local regulatory alignment, and supply chain transparency become essential components of commercial planning rather than back-office considerations.

Insights into how product formats animal categories analytical technologies clinical applications user types and distribution paths interact to shape development priorities and commercialization playbooks

Key segmentation insights reveal how differentiated needs across assay formats, animal populations, analytical technologies, clinical applications, end users, and distribution pathways drive product development and go-to-market decisions. Based on product type, diagnostics span Enzyme Linked Immunosorbent Assay and Lateral Flow Immunoassay formats, with ELISA further categorized into competitive, direct, indirect, and sandwich formats and lateral flow evolving to include competitive, multiplex, and sandwich designs that balance throughput, sensitivity, and simplicity. Based on animal type, solutions target companion animals and livestock populations where companion applications prioritize cats and dogs with a focus on outpatient clinical convenience, while livestock diagnostics address cattle, poultry, and swine where population-level screening, speed, and cost-efficiency dominate decision criteria.

Based on technology, the market encompasses colorimetric techniques, immunoassay platforms, and molecular diagnostics; immunoassay approaches further include chemiluminescence, ELISA, fluorescence, and lateral flow variants, whereas molecular diagnostics incorporate isothermal amplification and PCR modalities with isothermal methods subdividing into LAMP and RPA and PCR options spanning digital PCR and quantitative PCR. This technological stratification influences analytical sensitivity, user training needs, and instrumentation requirements. Based on application, diagnostic use cases include genetic tests, hormonal assays, infectious diseases, and parasitic infections, with genetic tests focusing on mutation detection and species identification, hormonal assays addressing reproductive and thyroid markers, infectious disease testing distinguishing bacterial, fungal, and viral etiologies, and parasitic diagnostics separating ectoparasite from endoparasite detection. Based on end user, the landscape engages clinical laboratories, pharmacies, research institutes, and veterinary hospitals, each with distinct procurement cycles, technical competencies, and data reporting expectations. Based on distribution channel, pathways span direct sales, eCommerce, and retail distributors, and the chosen channel influences customer engagement models, after-sales support, and inventory strategies.

Collectively, these segmentation layers inform product roadmaps and commercialization playbooks. For instance, multiplex lateral flow devices designed for poultry flock screening require different robustness and cost profiles than fluorescence-based immunoassays intended for specialty veterinary hospitals treating companion animals. Similarly, molecular diagnostics optimized for on-farm isothermal amplification balance ease of use with the need for minimal instrumentation, whereas qPCR and digital PCR solutions find traction in centralized laboratories that prioritize throughput and quantitation. Understanding these interdependencies helps companies prioritize investments, tailor regulatory submissions, and align distribution models with target end-user workflows.

Regional diagnostic ecosystems reveal distinct regulatory, infrastructure, and adoption patterns that drive differentiated strategies across Americas Europe Middle East Africa and Asia-Pacific

Geographic dynamics continue to define strategic priorities as regional regulatory frameworks, animal health infrastructures, and end-user behaviors diverge across major territories. In the Americas, diagnostic adoption is driven by integrated veterinary networks, sophisticated clinical laboratories, and a strong focus on companion animal wellness that supports demand for high-performance point-of-care solutions. The United States and parts of Latin America present contrasting procurement patterns, where centralized laboratory services remain important for large agricultural producers while independent clinics drive demand in urban companion animal markets.

In Europe, Middle East & Africa, fragmentation in regulatory regimes and varying levels of veterinary infrastructure create both complexity and opportunity. Western European markets emphasize compliance and clinical validation, reinforcing demand for assays that meet harmonized standards, while emerging markets across the region seek cost-effective, robust diagnostics that tolerate challenging logistics. The Middle East and select African markets often prioritize rapid deployment and simplicity to support outbreak response and routine herd-health management.

The Asia-Pacific region combines rapid adoption of advanced molecular diagnostics with large-scale livestock operations that demand scalable screening tools. Innovative distribution models and expanding eCommerce channels accelerate time-to-clinic for new products, and regional manufacturing capacity continues to rise, offering domestic suppliers competitive advantages in local markets. Across all regions, cross-border regulatory alignment efforts, investments in veterinary training, and digitization of diagnostic workflows are consistent themes that influence supplier strategy and product differentiation.

Company-level competitive advantages arise from technology integration regulatory rigor distribution scale and collaborative partnerships that accelerate adoption and sustain clinical trust

Competitive dynamics among companies operating in the veterinary rapid test landscape center on a few strategic dimensions: technological differentiation, regulatory and quality assurance capabilities, distribution reach, and the ability to deliver integrated solutions across hardware, reagents, and software. Market leaders typically pair validated assay chemistries with reliable point-of-care instruments and invest in post-market surveillance to sustain clinical confidence. Mid-sized innovators often focus on niche applications or animal segments where they can demonstrate clear performance advantages or cost efficiencies.

Partnerships and strategic alliances have become frequent mechanisms for accelerating market entry. Collaborations that combine diagnostic know-how with veterinary service providers, contract manufacturers, or digital health platforms can shorten time-to-adoption and broaden addressable markets. In addition, acquisitions that integrate complementary technologies, such as pairing molecular amplification expertise with rapid lateral flow reporting systems, enable firms to offer end-to-end diagnostic workflows.

Effective commercialization also depends on customer support and education. Companies that provide robust training materials, user-friendly digital guides, and responsive technical support secure higher levels of clinician trust and repeat procurement. Finally, firms that proactively engage with regulators and standards bodies to shape validation protocols and post-market surveillance practices reduce uncertainty and create barriers to entry for less-prepared competitors.

Practical strategic moves for diagnostic companies to accelerate adoption enhance resilience and create defensible commercial positions through design manufacturing distribution and partnerships

Industry leaders should pursue several actionable priorities to capture value while advancing animal health outcomes. First, accelerate user-centered product design that lowers training requirements and integrates with existing clinical workflows to maximize bedside utility. Second, invest in modular manufacturing and regional supply chains to mitigate tariff exposure and ensure continuity of supply under dynamic trade conditions. Third, prioritize strategic regulatory engagement and structured post-market evidence generation to demonstrate real-world performance and support broader clinical acceptance.

In addition, firms should expand distribution models by combining direct sales channels with eCommerce and selected retail distributor partnerships to meet diverse procurement preferences among clinical laboratories, veterinary hospitals, pharmacies, and research institutes. Vendors can also benefit from commercializing bundled offerings that pair diagnostics with data analytics and telemedicine services, thereby increasing the utility of test results and creating recurring revenue streams. Finally, pursue selective partnerships or technology licensing arrangements to accelerate access to complementary capabilities, while maintaining core competencies in assay development and quality management. Implementing these recommendations in an integrated manner will improve resilience and create a defensible competitive position across animal segments and geographies.

A transparent mixed-methods research approach combining stakeholder interviews regulatory literature and scenario-based analysis to derive actionable diagnostic insights

The research methodology underpinning this executive summary blends qualitative and quantitative approaches to build a robust evidence base while ensuring practical relevance to decision-makers. Primary research involved structured interviews and consultations with a cross-section of stakeholders, including veterinary clinicians, laboratory directors, procurement specialists, and diagnostics developers, to capture real-world needs, workflow constraints, and procurement behaviors. Secondary research synthesized peer-reviewed literature, regulatory guidance documents, and industry technical white papers to validate technological trends and standards of performance.

Analytical methods emphasized triangulation to reconcile disparate data points: technology performance attributes were cross-checked against clinical use cases and end-user expectations, while supply chain and tariff impacts were evaluated through scenario analysis to reveal strategic implications without relying on specific price forecasts. The methodology prioritized transparency in assumptions and documented limitations so that readers can interpret findings in the context of their own risk tolerance and operational constraints. Where appropriate, testing protocols and validation parameters were referenced to provide clarity on comparative performance claims across assay types.

A concise synthesis emphasizing the convergence of technological progress operational fit and strategic supply chain choices that determine diagnostic adoption outcomes

In conclusion, the veterinary rapid test ecosystem stands at the intersection of technical progress and practical imperatives. Advances in immunoassay and molecular technologies deliver improved analytical capabilities, while changes in care delivery models and procurement dynamics require diagnostics to be not only accurate but also accessible, affordable, and operationally fit for purpose. Trade policy fluctuations, including tariff shifts, further underscore the need for supply chain agility and regionally informed manufacturing strategies.

For industry stakeholders, the immediate priority is to align product development and commercialization plans with the nuanced needs of different animal types, end-users, and regional contexts. Companies that integrate user-centered product design, regulatory readiness, and distribution flexibility will be best positioned to capture adoption opportunities. Equally important is the cultivation of partnerships that extend technical capabilities and accelerate market access. By synthesizing these elements-technology, workflow integration, supply chain resilience, and strategic collaboration-organizations can convert diagnostic innovation into measurable improvements in animal health and operational outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of point-of-care rapid diagnostic tests in routine livestock health management to reduce disease outbreak risks
  • 5.2. Adoption of multiplex lateral flow assays for simultaneous detection of multiple animal pathogens in field settings
  • 5.3. Development of portable microfluidic devices enabling on-farm detection of zoonotic diseases in real time
  • 5.4. Increase in demand for smartphone-based rapid immunoassay platforms in small animal clinics and shelters
  • 5.5. Collaboration between biotech companies and veterinary associations to standardize rapid test validation protocols across regions
  • 5.6. Emergence of CRISPR-based diagnostic assays offering enhanced sensitivity for early detection of animal health threats in clinics
  • 5.7. Rising investment in veterinary diagnostic start-ups focusing on isothermal nucleic acid amplification for on-site testing of livestock diseases

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Veterinary Rapid Test Market, by Product Type

  • 8.1. Enzyme Linked Immunosorbent Assay
    • 8.1.1. Competitive
    • 8.1.2. Direct
    • 8.1.3. Indirect
    • 8.1.4. Sandwich
  • 8.2. Lateral Flow Immunoassay
    • 8.2.1. Competitive
    • 8.2.2. Multiplex
    • 8.2.3. Sandwich

9. Veterinary Rapid Test Market, by Animal Type

  • 9.1. Companion Animals
    • 9.1.1. Cats
    • 9.1.2. Dogs
  • 9.2. Livestock
    • 9.2.1. Cattle
    • 9.2.2. Poultry
    • 9.2.3. Swine

10. Veterinary Rapid Test Market, by Technology

  • 10.1. Colorimetric Techniques
  • 10.2. Immunoassay
    • 10.2.1. Chemiluminescence
    • 10.2.2. ELISA
    • 10.2.3. Fluorescence
    • 10.2.4. Lateral Flow
  • 10.3. Molecular Diagnostics
    • 10.3.1. Isothermal Amplification
      • 10.3.1.1. LAMP
      • 10.3.1.2. RPA
    • 10.3.2. PCR
      • 10.3.2.1. Digital PCR
      • 10.3.2.2. qPCR

11. Veterinary Rapid Test Market, by Application

  • 11.1. Genetic Tests
    • 11.1.1. Mutation Detection
    • 11.1.2. Species Identification
  • 11.2. Hormonal Assays
    • 11.2.1. Reproductive
    • 11.2.2. Thyroid
  • 11.3. Infectious Diseases
    • 11.3.1. Bacterial
    • 11.3.2. Fungal
    • 11.3.3. Viral
  • 11.4. Parasitic Infections
    • 11.4.1. Ectoparasite
    • 11.4.2. Endoparasite

12. Veterinary Rapid Test Market, by End User

  • 12.1. Clinical Laboratories
  • 12.2. Pharmacies
  • 12.3. Research Institutes
  • 12.4. Veterinary Hospitals

13. Veterinary Rapid Test Market, by Distribution Channel

  • 13.1. Direct Sales
  • 13.2. eCommerce
  • 13.3. Retail Distributors

14. Veterinary Rapid Test Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Veterinary Rapid Test Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Veterinary Rapid Test Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. IDEXX Laboratories, Inc.
    • 17.3.2. Zoetis Inc.
    • 17.3.3. Abbott Laboratories
    • 17.3.4. Thermo Fisher Scientific Inc.
    • 17.3.5. Heska Corporation
    • 17.3.6. Merck & Co., Inc.
    • 17.3.7. Boehringer Ingelheim International GmbH
    • 17.3.8. Bimeda, Inc.
    • 17.3.9. ACON Laboratories, Inc.
    • 17.3.10. BioNote Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VETERINARY RAPID TEST MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS VETERINARY RAPID TEST MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA VETERINARY RAPID TEST MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA VETERINARY RAPID TEST MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA VETERINARY RAPID TEST MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE VETERINARY RAPID TEST MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST VETERINARY RAPID TEST MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA VETERINARY RAPID TEST MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC VETERINARY RAPID TEST MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN VETERINARY RAPID TEST MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC VETERINARY RAPID TEST MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION VETERINARY RAPID TEST MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS VETERINARY RAPID TEST MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 VETERINARY RAPID TEST MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO VETERINARY RAPID TEST MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. VETERINARY RAPID TEST MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. VETERINARY RAPID TEST MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. VETERINARY RAPID TEST MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL VETERINARY RAPID TEST MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL VETERINARY RAPID TEST MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COMPETITIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COMPETITIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COMPETITIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COMPETITIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COMPETITIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COMPETITIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY DIRECT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY DIRECT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY DIRECT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY DIRECT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY DIRECT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY DIRECT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY INDIRECT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY INDIRECT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY INDIRECT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY INDIRECT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY INDIRECT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY INDIRECT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SANDWICH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SANDWICH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SANDWICH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SANDWICH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SANDWICH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SANDWICH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COMPETITIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COMPETITIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COMPETITIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COMPETITIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COMPETITIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COMPETITIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY MULTIPLEX, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY MULTIPLEX, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY MULTIPLEX, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY MULTIPLEX, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY MULTIPLEX, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY MULTIPLEX, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SANDWICH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SANDWICH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SANDWICH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SANDWICH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SANDWICH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SANDWICH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COMPANION ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COMPANION ANIMALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COMPANION ANIMALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COMPANION ANIMALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COMPANION ANIMALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CATS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CATS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CATS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CATS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CATS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CATS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY DOGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY DOGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY DOGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY DOGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY DOGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY DOGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LIVESTOCK, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LIVESTOCK, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LIVESTOCK, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LIVESTOCK, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LIVESTOCK, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LIVESTOCK, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CATTLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CATTLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CATTLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CATTLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CATTLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY POULTRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY POULTRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY POULTRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY POULTRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY POULTRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SWINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SWINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SWINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SWINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SWINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COLORIMETRIC TECHNIQUES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COLORIMETRIC TECHNIQUES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COLORIMETRIC TECHNIQUES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COLORIMETRIC TECHNIQUES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COLORIMETRIC TECHNIQUES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COLORIMETRIC TECHNIQUES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY IMMUNOASSAY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CHEMILUMINESCENCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CHEMILUMINESCENCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CHEMILUMINESCENCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CHEMILUMINESCENCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CHEMILUMINESCENCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CHEMILUMINESCENCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ELISA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ELISA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ELISA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ELISA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY FLUORESCENCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY FLUORESCENCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY FLUORESCENCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY FLUORESCENCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY FLUORESCENCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY FLUORESCENCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LATERAL FLOW, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LATERAL FLOW, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LATERAL FLOW, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LATERAL FLOW, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LATERAL FLOW, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LATERAL FLOW, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LAMP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LAMP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LAMP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LAMP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LAMP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LAMP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY RPA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY RPA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY RPA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY RPA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY RPA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY RPA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PCR, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY DIGITAL PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY QPCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY QPCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY QPCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY QPCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY QPCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY QPCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY GENETIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY GENETIC TESTS, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY GENETIC TESTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY GENETIC TESTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY GENETIC TESTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY GENETIC TESTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY GENETIC TESTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY GENETIC TESTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY MUTATION DETECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY MUTATION DETECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY MUTATION DETECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY MUTATION DETECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY MUTATION DETECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY MUTATION DETECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SPECIES IDENTIFICATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SPECIES IDENTIFICATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SPECIES IDENTIFICATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SPECIES IDENTIFICATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SPECIES IDENTIFICATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SPECIES IDENTIFICATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY HORMONAL ASSAYS, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY HORMONAL ASSAYS, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY HORMONAL ASSAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY HORMONAL ASSAYS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY HORMONAL ASSAYS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY HORMONAL ASSAYS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY HORMONAL ASSAYS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY HORMONAL ASSAYS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY REPRODUCTIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY REPRODUCTIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY REPRODUCTIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY REPRODUCTIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY REPRODUCTIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY REPRODUCTIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY THYROID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY THYROID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY THYROID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY THYROID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY THYROID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY THYROID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY BACTERIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY BACTERIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY BACTERIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY BACTERIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY BACTERIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY FUNGAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY FUNGAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY FUNGAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY FUNGAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY FUNGAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY FUNGAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY VIRAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY VIRAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY VIRAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY VIRAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY VIRAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY VIRAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PARASITIC INFECTIONS, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PARASITIC INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PARASITIC INFECTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PARASITIC INFECTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PARASITIC INFECTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PARASITIC INFECTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PARASITIC INFECTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ECTOPARASITE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ECTOPARASITE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ECTOPARASITE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ECTOPARASITE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ECTOPARASITE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ECTOPARASITE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ENDOPARASITE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ENDOPARASITE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ENDOPARASITE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ENDOPARASITE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ENDOPARASITE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ENDOPARASITE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 291. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 292. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CLINICAL LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CLINICAL LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CLINICAL LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 296. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CLINICAL LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 297. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 298. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 299. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 300. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 301. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 302. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 303. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 304. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 305. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 306. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 307. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 308. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 309. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 310. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 311. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 312. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 313. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 314. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 315. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 316. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 317. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY